3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Classical hematology
1
Conditions
Carcinoma, Non-Small-Cell Lung
438
Breast Neoplasms
383
Neoplasms
292
Prostatic Neoplasms
196
Neoplasm Metastasis
156
Multiple Myeloma
148
Colorectal Neoplasms
124
Lung Neoplasms
105
Ovarian Neoplasms
102
Parkinson Disease 4, Autosomal Dominant Lewy Body
98
Melanoma
95
Lymphoma, Follicular
94
Recurrence
88
Lymphoma, Non-Hodgkin
82
Papillomavirus Infections
81
Leukemia, Lymphocytic, Chronic, B-Cell
81
Carcinoma, Hepatocellular
81
Stomach Neoplasms
76
Small Cell Lung Carcinoma
73
Leukemia, Myeloid, Acute
70
Pancreatic Neoplasms
67
Pain
66
Carcinoma, Renal Cell
65
Uterine Cervical Neoplasms
64
Keratosis, Actinic
63
Urinary Bladder Neoplasms
59
Myasthenia Gravis
53
Lymphoma, Large B-Cell, Diffuse
53
Leiomyoma
49
Carcinoma
49
Interventions
BIVV001
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
INDUSTRY
×
Coagulation Protein Disorders
×
Clear all
NCT06716814
2026-04-20
LIBERTY
Swedish Orphan Biovitrum
Phase 3
Recruiting
104 enrolled